Suppr超能文献

耐药性癫痫发作控制的意外改善——真实世界观察。

Unanticipated improvement in seizure control in drug-resistant epilepsy- real world observations.

机构信息

Department of Neurology, Cork University Hospital, Ireland.

Department of Neurology, Cork University Hospital, Ireland; College of Medicine and Health, University College Cork, Ireland.

出版信息

Seizure. 2021 Jan;84:60-65. doi: 10.1016/j.seizure.2020.11.005. Epub 2020 Nov 21.

Abstract

OBJECTIVES

To determine the clinical features and anti-seizure medication (ASM) strategies associated with an unanticipated substantial improvement in seizure control in patients with drug-resistant epilepsy (DRE).

METHODS

This retrospective analysis of patients attending a tertiary care epilepsy clinic between 2008 and 2017 identified all patients with active DRE (at least 1 seizure per month for 6 months, despite treatment with 2 different ASMs). All treatment interventions were recorded from when DRE was first identified to the end of the study. The primary end points were seizure freedom or meaningful reduction in seizure frequency (greater than 75 %) sustained for at least 12 months after a treatment intervention.

RESULTS

Three hundred and twenty-two patients were included in the analysis. Overall, 10 % became seizure free following ASM adjustment and an additional 10 % had a greater than 75 % improvement in seizure control (median follow-up, 4 years). An ASM introduction was ten times more likely than an ASM dose increase to improve seizure control. Combined focal and generalized epilepsy, intellectual disability and prior treatment with more than 5 ASMs were more frequently observed in those with continued pharmacoresistance. ASM responders were more likely to have primary generalized epilepsy. Rational polytherapy (combining ASMs with different mechanisms of action) was almost ubiquitous amongst ASMs responders (95 % taking at least 2 drugs with different mechanistic targets). Of the ASM additions that heralded improved seizure control, 85 % were maintained at submaximal doses.

CONCLUSIONS

This retrospective analysis of a large number of 'real-world' patients provides evidence to persist with ASM trials in DRE. Early rotation of ASMs if a clinical response is not observed at a substantial dose and rational ASM polytherapy may yield better clinical outcomes in patients with DRE, although a prospective study would need to be conducted to validate these findings.

摘要

目的

确定与耐药性癫痫(DRE)患者的癫痫发作控制出现意外显著改善相关的临床特征和抗癫痫药物(ASM)策略。

方法

这项对 2008 年至 2017 年间在三级护理癫痫诊所就诊的患者进行的回顾性分析确定了所有患有活动性 DRE 的患者(尽管使用了 2 种不同的 ASM,仍每月至少发作 1 次,持续 6 个月)。从首次发现 DRE 到研究结束,记录了所有治疗干预措施。主要终点是在治疗干预后至少 12 个月内无癫痫发作或癫痫发作频率有明显降低(>75%)。

结果

共纳入 322 例患者进行分析。总体而言,10%的患者在调整 ASM 后实现了无癫痫发作,另有 10%的患者癫痫发作控制有了>75%的改善(中位随访时间为 4 年)。与增加 ASM 剂量相比,引入新的 ASM 更有可能改善癫痫发作控制。持续药物抵抗的患者更常出现局灶性和全面性癫痫合并、智力障碍和以前使用超过 5 种 ASM。ASM 应答者更可能患有原发性全面性癫痫。合理的多药治疗(将具有不同作用机制的 ASM 联合使用)在 ASM 应答者中几乎无处不在(95%的患者至少服用 2 种具有不同机制靶点的药物)。在预示癫痫发作控制改善的 ASM 添加中,85%的药物以亚最大剂量维持。

结论

这项对大量“真实世界”患者的回顾性分析为 DRE 中继续进行 ASM 试验提供了证据。如果在大剂量下未观察到临床反应,应及早更换 ASM,如果合理地进行 ASM 多药治疗,可能会改善 DRE 患者的临床结局,尽管需要进行前瞻性研究来验证这些发现。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验